Resolution of Metastatic Subungal Eccrine Porocarcinoma Treated with Intralesional Interleukin-2.
immunotherapy
interleukin-2
porocarcinoma
Journal
Current oncology (Toronto, Ont.)
ISSN: 1718-7729
Titre abrégé: Curr Oncol
Pays: Switzerland
ID NLM: 9502503
Informations de publication
Date de publication:
30 12 2020
30 12 2020
Historique:
received:
18
04
2020
revised:
11
11
2020
accepted:
11
11
2020
entrez:
11
3
2021
pubmed:
12
3
2021
medline:
25
9
2021
Statut:
epublish
Résumé
Eccrine porocarcinoma is a rare aggressive cutaneous malignancy. Complete surgical excision is the standard of care, although there are high rates of local and distant recurrence. We present a unique case of locally recurrent and metastatic subungal porocarcinoma successfully treated with intralesional interleukin-2.
Identifiants
pubmed: 33704189
pii: curroncol28010024
doi: 10.3390/curroncol28010024
pmc: PMC7900891
doi:
Substances chimiques
Interleukin-2
0
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
220-225Références
J Clin Oncol. 1999 Jul;17(7):2105-16
pubmed: 10561265
J Dermatol. 2015 Sep;42(9):928-30
pubmed: 26073009
Ann Surg Oncol. 2015;22(6):1950-8
pubmed: 25366584
Dermatol Surg. 2018 Oct;44(10):1247-1261
pubmed: 29894433
Clin Cancer Res. 2008 Sep 1;14(17):5610-8
pubmed: 18765555
Dermatol Surg. 2015 Jul;41(7):853-4
pubmed: 26079590
Int J Dermatol. 2015;54(5):580-6
pubmed: 25515648
Dermatol Ther. 2019 Mar;32(2):e12830
pubmed: 30659720
Arch Dermatol. 1992 Aug;128(8):1127-8
pubmed: 1323244
Int J Surg Case Rep. 2017;30:13-16
pubmed: 27898349
Eur J Cancer. 2018 Feb;90:142-145
pubmed: 29233613
Expert Opin Biol Ther. 2016;16(5):619-26
pubmed: 26898656
Dermatol Surg. 2016 Jun;42(6):745-50
pubmed: 27176862
Int J Dermatol. 2015 Nov;54(11):e503-5
pubmed: 26234455
Int J Dermatol. 2017 Sep;56(9):899-901
pubmed: 28078732
Curr Opin Chem Biol. 2014 Dec;23:39-46
pubmed: 25271022
Cancer. 2008 Jul 15;113(2):293-301
pubmed: 18457330
Dermatol Surg. 2017 Jul;43(7):995-996
pubmed: 28328706